Need of Pharmacovigilance in Herbals
The first and foremost issue with herbals as medicines is the undefined toxicological data. Since most of the literature or traditional knowledge is scattered in the case of herbals, it makes the scientific world to access the safety and toxicological profiles of most of the herbs. [7] Standardization of herbal formulations and drugs is essential in order to assess the quality, based on the concentration of their active principles [ Figure 1 ]. The adverse effects of the end users are not being monitored, which leads to chaos in the mind of researchers, which needs to have dose-related effects of the herbal medicines. In view of the same, the World Health Organization (WHO) Collaborating Centre for International Drug Monitoring has recommended the use of proper scientific binomial names for herbs used in medicine in order to track and record the same for further references and researches. [8] This database will certainly lead to significant comparability between various national and international platforms. Moreover, the adulteration in the name of herbals has been consistently reported, which have further reduced the interest of scientific community toward herbals.
There are several countries, which widely accept traditional and experience based evidence in the case of herbals while the others doubt the integrity of such medicines from herbal source. The pharmacovigilance of herbal medicinal products will definitely go a long way in restoring the confidence of researchers and end users for their safety and efficacy.
Regulatory Status of Herbal Medicines in India
The regulatory status of herbals in India is somewhat different from other countries as India have folk and traditional knowledge of time-tested herbs and their use as medicines. [9] What India lacks is the regulatory approvals of these herbal medicines as these herbal medicines are not known with exact safety, efficacy, and quality to support the data from scientific world and the data which are available is not comparable globally in terms of clinical and scientific evidence. [10] There should be a stringent criterion for different nature of herbals, and there should be different divisions to submit toxicity data and clinical trial data.
The Emergence of Pharmacovigilance of Herbal Medicines in India
The importance and awareness of pharmacovigilance of herbal medicines have been on the constant rise in India since 2003 with the Constitution of the National Pharmacovigilance Program of India, which is operating under the control of the Central Drug Standards Control Organization. [11] Apart from this, WHO has also emphasized that traditional medicines should be included in pharmacovigilance system and has already published guidelines in 2004 on the safety monitoring of herbal medicines in pharmacovigilance systems.
This move was followed by many government departments in India including the Department of Ayurveda, Yoga, Unani, Siddha, Homoeopathy, Ministry of Health and Family Welfare, Government of India, New Delhi, which initiated pharmacovigilance program for Ayurvedic, Siddha, and Unani drugs also. [12] The list of significant events in the field of herbal pharmacovigilance in India is given in Table 1 .
Pharmacovigilance of Herbal Medicines in India Challenges Ahead
The pharmacovigilance program in India is although been practiced and implemented in a war scale status; the practice apparently suffers from many glitches. First, the reporting of adverse events related to herbal drugs is abysmally quite low in spite of multi-initiatives by the government to facilitate these reporting. [13, 14] Following the reporting, the detection of adverse events are not significantly done as the names, toxicological profiling, and detections criterion To add on to these hindrances, lack of trained and qualified professionals with an inability to correlate the things and misjudging the active ingredient, mechanism of action and toxicological symptoms play an important role. [15, 16] 
Conclusion
The pharmacovigilance program concept regarding herbals should be introduced at graduate and post graduate levels. Vigilance in terms of adverse drug reaction and adverse event monitoring of herbals and signal generation should be of high priority. Trained pharmacovigilance professionals is an important part of this program and should play an important role in monitoring regulatory control and strengthen the existing pharmacovigilance programs.
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